Immunotec has bolstered its presence in the U.S. with a new Sales Office in Commerce, California. The 7,200 square-foot facility opened last week to support strong sales and distributor growth across the country’s southwestern region, says Canada-based Immunotec.
The nutrition company reported Q3 revenue of $22.3 million, up 55 percent over the prior year period. In the U.S., revenue increased 27 percent in the third quarter. Immunotec now operates regional offices in the U.S. and in Mexico, in addition to its Quebec headquarters.
“Opening this new sales office in the southwestern region of the United States represents the result of the hard work and dedication of our Distributors who are investing in themselves, their families and everyone they touch as they share our mission to make Immunocal the nutritional choice of households worldwide,” CEO Charles L. Orr shared in a statement.
Immunocal is the company’s patented, specially formulated protein derived from whey. The immune health product, which has undergone over 40 years of clinical research and testing, played a key part in Immunotec’s recent research collaboration with Dr. Franco Carli, MD, MPh, Anesthesiologist at the McGill University Health Centre in Montreal. The study recorded the impact of surgical prehabilitation (preoperative intervention) versus rehabilitation on a patient’s recovery time.
“Surgical prehabilitation is a novel concept, aimed to aid patients to become stronger physically, nutritionally and mentally while waiting for an operation and therefore be in better shape to overcome the stress of surgery,” said the Lead Investigator, Dr. Franco Carli.
|Immunotec’s Commerce, California, Sales Office||Immunotec’s Charles Orr (left), CEO, and Juan Manuel Marín (right), Executive Diamond Distributor, cut the ceremonial ribbon|